Agaoglu, L. Et Al. 2001. Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. JOURNAL OF CHEMOTHERAPY , vol.13, no.3 , 281-287.

Agaoglu, L., Devecioglu, O., Anak, S., Karakas, Z., Yalman, N., Biner, B., ... Eryilmaz, E.(2001). Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. JOURNAL OF CHEMOTHERAPY , vol.13, no.3, 281-287.

Agaoglu, L Et Al. "Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey," JOURNAL OF CHEMOTHERAPY , vol.13, no.3, 281-287, 2001

Agaoglu, L Et Al. "Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey." JOURNAL OF CHEMOTHERAPY , vol.13, no.3, pp.281-287, 2001

Agaoglu, L. Et Al. (2001) . "Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey." JOURNAL OF CHEMOTHERAPY , vol.13, no.3, pp.281-287.

@article{article, author={L Agaoglu Et Al. }, title={Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey}, journal={JOURNAL OF CHEMOTHERAPY}, year=2001, pages={281-287} }